Skip to main content
Fig. 4 | BMC Endocrine Disorders

Fig. 4

From: Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial

Fig. 4

Comparison of skeletal maturity and changes in IGF-1 and IGFBP-3 levels from baseline. a Skeletal maturity (ratio of change in bone age/chronological age), b Change in IGF-1 level from baseline, c: Change in IGFBP-3 level from baseline. IGF-1: Insulin-like Growth Factor-1; IGFBP-3: Insulin-like Growth Factor Binding Protein-3. * Two sample t-test between treatment groups; **: Wilcoxon rank sum test between treatment groups

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us